Related Experiment Video
Updated: Jun 18, 2026
05:56
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
Pharmacogenetics of asthma therapy
Qing Ling Duan1, Kelan G Tantisira
1Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. reqdu@channing.harvard.edu
Current Pharmaceutical Design
|November 21, 2009
Summary
Genetic factors influence how individuals respond to asthma medications. Understanding these genetic variations can help predict drug efficacy and avoid adverse reactions for better asthma management.
Area of Science:
- Pharmacogenetics
- Respiratory Medicine
- Clinical Pharmacology
Background:
- Asthma affects 300 million globally, with increasing incidence and healthcare costs.
- Current asthma medications (beta-agonists, leukotriene modifiers, corticosteroids) are ineffective for up to 50% of patients.
- Heritability of asthma and drug response (e.g., FEV(1)) suggests a genetic basis for variable treatment outcomes.
Purpose of the Study:
- To review pharmacogenetic findings for major asthma drug classes.
- To discuss limitations in current genetic studies.
- To propose future research directions for identifying novel genetic factors.
Main Methods:
- Literature review of pharmacogenetic studies on asthma medications.
- Analysis of genetic associations with drug response phenotypes.
- Discussion of study limitations and future research needs.
Main Results:
- Numerous genes linked to variable responses to asthma drugs, but findings are often contradictory.
- Genetic variants demonstrably influence patient response to common asthma treatments.
- Replication in larger cohorts is needed to confirm initial findings.
Conclusions:
- Pharmacogenetics plays a crucial role in variable asthma drug response.
- Genetic testing may enable personalized asthma treatment strategies.
- Future research should focus on validating genetic markers and identifying new ones for improved patient outcomes.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...